Nursing experts discuss the emergence of immunotherapy in GI cancers, focusing on the role of biomarkers and the management of irAEs.
This activity is intended for nurses and other healthcare professionals who manage patients with gastrointestinal cancers.
The goal of this activity is to discuss the emerging role of immunotherapy using immune checkpoint inhibitors in patients with gastrointestinal cancers.
Approximate Time to Complete: 30 minutes
Credit Available: Apr. 30, 2019 - Apr. 30, 2020
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge regarding the use of cancer immunotherapy regimens in gastrointestinal cancers
- Have greater competence related to the role of biomarker testing prior to use of cancer immunotherapies
- Have greater competence related to the management of immune-related adverse events in patients with gastrointestinal cancers